Evaluasi Rasionalitas Insulin Pada Pasien Diabetes Mellitus Tipe 2 Rawat Jalan di RSUD Kota Madiun Periode 2022

Fitria Wahyuning Wulan; Lelly Winduhani Astuti; Fentyana Dwi Rilawati; Akbar Firdaus Syam

doi:10.55606/termometer.v2i3.4054

Authors

Fitria Wahyuning Wulan Institut Ilmu Kesehatan Bhakti Wiyata Kediri
Lelly Winduhani Astuti Institut Ilmu Kesehatan Bhakti Wiyata Kediri
Fentyana Dwi Rilawati Institut Ilmu Kesehatan Bhakti Wiyata Kediri
Akbar Firdaus Syam Institut Ilmu Kesehatan Bhakti Wiyata Kediri

DOI:

https://doi.org/10.55606/termometer.v2i3.4054

Keywords:

DM type 2, Single insulin, Combined insulin

Abstract

Diabetes mellitus (DM) is a group of metabolic diseases characterized by hyperglycemia that occurs due to defects in insulin secretion, insulin action or both. Diabetes mellitus (DM) is currently a global health threat. Various epidemiological studies have shown an increase in the incidence and prevalence of DM in the world. Based on data from the profile of the East Java Health Office in 2021, it is estimated that DM patients in Madiun City rank fourth in the East Java region. . Objective: This research was conducted to determine the evaluation of the rationality of insulin in type 2 DM patients in the Outpatient Hospital of Madiun City Hospital for the period 2022. Methods: This research method is in the form of an observational research, retrospective data collection in the form of medical records of history of type 2 diabetes mellitus patients at Outpatient Hospital at RSUD Madison City. The total population in this study in the period January - December 2022 was 165 patients. Results: From the 62 type 2 DM patients who were outpatients at Madiun City Regional Hospital, it was found that 14.52% using single insulin and 12.90% used Detemir insulin. The use of the insulin combination was 85.48% and the Detemir – Aspart insulin combination was 58.06%. Conclusion: Evaluation of the rationality of insulin use showed that the correct drug was 100% and the correct dose was 93,55%.

Downloads

Download data is not yet available.

References

ADA. (2020). Standards of medical care in diabetes. Clinical Diabetes, 38(1), 10–38. https://doi.org/10.2337/cd20-as01

Dinkes Jatim. (2021). Profil kesehatan Dinas Kesehatan Provinsi Jawa Timur 2021 (pp. 1–149). Dinas Kesehatan Provinsi Jawa Timur.

Dipiro, J. T., Schwinghammer, T. L., & DiPiro, C. V. (2015). Pharmacotherapy handbook (9th ed.). McGraw-Hill Education.

Fahmi, K. N., & Urfiyya, Q. A. (2021). Rawat jalan di RSI Hidayatullah Yogyakarta: An overview insulin used in outpatient with diabetes mellitus type 2 at Hidayatullah Islamic Yogyakarta Hospital. Diabetes Mellitus, 4(1), 12–21.

Fef Rukminingsih, V. C. N. (2021). Penggunaan insulin pada pasien diabetes melitus tipe 2 peserta JKN di instalasi farmasi rawat jalan Rumah Sakit St. Elisabeth Semarang. Jurnal Ilmiah Ibnu Sina, 6(1), 69–78. https://doi.org/10.36387/jiis.v6i1.609

Hongdiyanto, A., Yamlean, P. V. Y., & Supriati, S. (2014). Evaluasi kerasionalan pengobatan diabetes melitus tipe 2 pada pasien rawat inap di RSUP Prof. Dr. R. D. Kandou Manado tahun 2013. Pharmacon Jurnal Ilmiah Farmasi, 3(2), 77–87.

IDF. (2021). International Diabetes Federation. Diabetes Research and Clinical Practice, 102(2). https://doi.org/10.1016/j.diabres.2013.10.013

Infodatin. (2020). Infodatin tetap produktif, cegah, dan atasi diabetes melitus 2020. Pusat Data dan Informasi Kementerian Kesehatan RI, 1–10.

Kartika, I. G. A., Lestari, A. A., & Swastini, D. A. (2013). Perbandingan profil penggunaan terapi kombinasi insulin pada pasien diabetes mellitus tipe 2 di unit rawat inap Rumah Sakit Umum Pusat Sanglah. Jurnal Farmasi Udayana, 2(2), 62–69.

Kemenkes RI. (2011). Modul penggunaan obat rasional 2011 (pp. 3–4).

Kemenkes. (2018). Formularium Nasional, 1(1), 1–8.

Notoadmojo, S. (2018). Metodologi penelitian kesehatan.

Nyoman, N., Udayani, W., Luh, N., Mega, A., Cahyaningsih, E., & Wardani, I. G. A. A. K. (2021). Evaluasi efek samping penggunaan kombinasi insulin pada pasien rawat jalan diabetes melitus tipe 2 di salah satu rumah sakit kota Denpasar. Jurnal Ilmiah Medicamento, 7(2), 112–117.

PERKENI. (2021a). Pedoman pengelolaan dan pencegahan diabetes melitus tipe 2 di Indonesia. Global Initiative for Asthma.

PERKENI. (2021b). Pedoman petunjuk praktis terapi insulin pada pasien diabetes mellitus 2021 (pp. 32–39). Pb Perkeni.

Purwakanthi, A., Shafira, N. N. A., Harahap, H., & Kusdiyah, E. (2020). Gambaran penggunaan obat diabetes mellitus pada pasien diabetes mellitus tipe 2. Jambi Medical Journal: Jurnal Kedokteran dan Kesehatan, 8(1), 40–46. https://doi.org/10.22437/jmj.v8i1.9483

Riskesdas. (2018). Hasil riset kesehatan dasar tahun 2018. Kementerian Kesehatan RI, 53(9), 1689–1699.

Sugiyono. (2018). Metode penelitian kombinasi (mixed methods).